Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis

BACKGROUND: For prolactinoma patients, dopamine agonists (DAs) are indicated as the first-line treatment and surgery is an adjunctive choice. However, with the development of surgical technique and equipment, the effect of surgery has improved. The aim of this study was to assess the efficacy and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiangming, Zhu, Junhao, Yang, Jin, Tang, Chao, Cong, Zixiang, Ma, Chiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994364/
https://www.ncbi.nlm.nih.gov/pubmed/35395837
http://dx.doi.org/10.1186/s41016-022-00277-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994364/
https://www.ncbi.nlm.nih.gov/pubmed/35395837
http://dx.doi.org/10.1186/s41016-022-00277-1

Ejemplares similares